ENTRADA THERAPEUTICS INC

Ticker: TRDA CUSIP: 29384C108 Class: Common Stock

MOORE CAPITAL MANAGEMENT, LP's Holding History (CIK: 0001448574)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 105,000 Value ($000) $1,079 Avg Close Range
Q3 2025
Shares 105,000 Value ($000) $609 Avg Close Range
Q2 2025
Shares 105,000 Value ($000) $706 Avg Close Range
Q1 2025
Shares 105,000 Value ($000) $949 Avg Close Range
Q4 2024
Shares 105,000 Value ($000) $1,815 Avg Close Range
Q3 2024
Shares 105,000 Value ($000) $1,678 Avg Close Range
Q2 2024
Shares 105,000 Value ($000) $1,496 Avg Close Range
Q1 2024
Shares 105,000 Value ($000) $1,488 Avg Close Range
Q4 2023
Shares 105,000 Value ($000) $1,584 Avg Close Range
Q3 2023
Shares 105,000 Value ($000) $1,659 Avg Close Range
Q2 2023
Shares 105,000 Value ($000) $1,590 Avg Close Range
Q1 2023
Shares 105,000 Value ($000) $1,523 Avg Close Range
Q4 2022
Shares 105,000 Value ($000) $1,420 Avg Close Range
Q3 2022
Shares 105,000 Value ($000) $1,655 Avg Close Range
Q2 2022
Shares 105,000 Value ($000) $1,279 Avg Close Range
Q1 2022
Shares 105,000 Value ($000) $986 Avg Close Range
Q4 2021
Shares 105,000 Value ($000) $1,798 Avg Close Range